Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
暂无分享，去创建一个
M. Fukuoka | Hirokazu Watanabe | T. Taguchi | T. Satoh | Y. Hasegawa | I. Okamoto | A. Tsuya | K. Nakagawa | N. Masuda | S. Ueda | Y. Ariyoshi | Toshikazu Saito | M. Miyazaki | R. Morinaga | M. Terashima | Yohko Hashimoto | T. Kakihara | Yumiko Aoyama